Related references
Note: Only part of the references are listed.New dihydronaphthothiophene derivatives by the biological transformation of seriniquinone using marine-derived actinomycete Streptomyces albogriseolus OM27-12
Kohei Ishida et al.
JOURNAL OF ANTIBIOTICS (2022)
Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy
Jifa Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Seriniquinones as Therapeutic Leads for Treatment of BRAF and NRAS Mutant Melanomas
Amanda S. Hirata et al.
MOLECULES (2021)
Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling
Tyson W. Lager et al.
ONCOGENE (2021)
Prediction of seriniquinone-drug interactions by in vitro inhibition of human cytochrome P450 enzymes
Rodrigo Moreira da Silva et al.
TOXICOLOGY IN VITRO (2020)
Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study
Filippo Mancuso et al.
MOLECULAR ONCOLOGY (2020)
New insights on the role of autophagy in the pathogenesis and treatment of melanoma
Marveh Rahmati et al.
MOLECULAR BIOLOGY REPORTS (2020)
Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline
Alexsandra Conceicao Apolinario et al.
NANOMEDICINE (2020)
Advance of Seriniquinone Analogues as Melanoma Agents
Justin C. Hammons et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis
Laura Nunez-Naveira et al.
LUNG (2019)
Current state of melanoma diagnosis and treatment
Lauren E. Davis et al.
CANCER BIOLOGY & THERAPY (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cytochrome P450 Structure, Function and Clinical Significance: A Review
Palrasu Manikandan et al.
CURRENT DRUG TARGETS (2018)
The Role of Dermcidin in the Diagnosis and Staging of Hepatocellular Carcinoma
Feng Qiu et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)
Melanoma treatment: from conventional to nanotechnology
Harshita Mishra et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Dermcidin as a novel binding protein of lncRNA STCAT3 and its effect on prognosis in gastric cancer
Jianfeng Zhang et al.
ONCOLOGY REPORTS (2018)
Induction of N-Ras degradation by flunarizine-mediated autophagy
Ze-Yi Zheng et al.
SCIENTIFIC REPORTS (2018)
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Judy L. Bolton et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
Paclitaxel: What has been done and the challenges remain ahead
Ezequiel Bernabeu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cost-Effectiveness of Nivolumab-lpilimumab Combination Therapy Compared with Monotherapy for First-Line Treatment of Metastatic Melanoma in the United States
Anna Oh et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2017)
Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics
Laura M. Lopez-Sanchez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care
Markus V. Heppt et al.
BMC CANCER (2017)
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G. V. Long et al.
ANNALS OF ONCOLOGY (2017)
Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro
Oxana O. Ryabaya et al.
ANTI-CANCER DRUGS (2017)
Malformin A1 promotes cell death through induction of apoptosis, necrosis and autophagy in prostate cancer cells
Yongqing Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma
Idoia Ortega-Martinez et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
Jasna Bancovik et al.
BMC CANCER (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Trametinib: a MEK inhibitor for management of metastatic melanoma
Iwona Lugowska et al.
ONCOTARGETS AND THERAPY (2015)
Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma
Xiaoqi Xie et al.
CANCER DISCOVERY (2015)
The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents
Yan Yu et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
Targeted Therapies Compared to Dacarbazine for Treatment of BRAFV600E Metastatic Melanoma: A Cost-Effectiveness Analysis
Vanessa Shih et al.
JOURNAL OF SKIN CANCER (2015)
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
Dermcidin expression is associated with disease progression and survival among breast cancer patients
Heather Ann Brauer et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma
Patti Curl et al.
PLOS ONE (2014)
Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancer-protective protein dermcidin
Lynnie Trzoss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Targeting Mitochondrial Metabolism by Inhibiting Autophagy in BRAF-Driven Cancers
Anne M. Strohecker et al.
CANCER DISCOVERY (2014)
Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14
Jonathan W. Biggers et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Historical review of melanoma treatment and outcomes
Carrie Lee et al.
CLINICS IN DERMATOLOGY (2013)
The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF 600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use
Silvy da Rocha Dias et al.
EUROPEAN JOURNAL OF CANCER (2013)
Advances and perspectives in immunotherapy of melanoma
D. Schadendorf et al.
ANNALS OF ONCOLOGY (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Identification of Dermcidin as a novel binding protein of Nck1 and characterization of its role in promoting cell migration
Shun-Li Shen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Ammosamides A and B Target Myosin
Chambers C. Hughes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines
G. D. Stewart et al.
BRITISH JOURNAL OF CANCER (2008)
Autophagy fights disease through cellular self-digestion
Noboru Mizushima et al.
NATURE (2008)
Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia
Grant D. Stewart et al.
PROSTATE (2007)
Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues
A. G. Lowrie et al.
BRITISH JOURNAL OF CANCER (2006)
Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy
DAC Deans et al.
BRITISH JOURNAL OF CANCER (2006)
A central strategy for converting natural products into fluorescent probes
MD Alexander et al.
CHEMBIOCHEM (2006)
A neural survival factor is a candidate oncogene in breast cancer
D Porter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Dermcidin: a novel human antibiotic peptide secreted by sweat glands
B Schittek et al.
NATURE IMMUNOLOGY (2001)
Share Paper
